Literature DB >> 25337251

Alpha B-crystallin correlates with poor survival in colorectal cancer.

Chuanbing Shi1, Zhenyu He2, Ning Hou3, Yijiang Ni4, Lin Xiong5, Pingsheng Chen1.   

Abstract

Alpha B-crystallin (CRYAB) is primarily found as major structural proteins of the ocular lens and is a principal member of the small heat shock protein (HSP) family. So far, CRYAB has been suggested to play critical roles in the development of several kinds of human cancers. However, the association between CRYAB expression and clinicopathological characteristics of colorectal cancer (CRC) has not been elucidated yet. In the present study, one-step quantitative PCR reverse transcription-polymerase chain reaction (qPCR) analysis of 18 samples of CRC and immunohistochemistry (IHC) analysis with 100 cases of CRC sample in tissue microarrays (TMA) were employed to evaluate the expression of CRYAB in CRC. The results suggested that CRYAB expression in the mRNA and protein levels was significantly higher in CRC tissues than in corresponding non-cancerous tissues (P < 0.05 and P = 0.014, respectively). The expression of CRYAB protein in CRC was significantly associated with distant metastasis (P = 0.040) and overall survival (P = 0.003). Kaplan-Meier method and multivariate survival analysis indicated that high expression of CRYAB (P = 0.040) and distant metastasis (P = 0.005) showed significant correlations with poor prognosis of CRC patients. The data imply that CRYAB expression is correlated with substantial clinical characteristics of CRC, and it may be identified as an unfavorable prognostic factor for CRC.

Entities:  

Keywords:  CRC; CRYAB; IHC; TMA; qPCR

Mesh:

Substances:

Year:  2014        PMID: 25337251      PMCID: PMC4203222     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.

Authors:  Jose V Moyano; Joseph R Evans; Feng Chen; Meiling Lu; Michael E Werner; Fruma Yehiely; Leslie K Diaz; Dmitry Turbin; Gamze Karaca; Elizabeth Wiley; Torsten O Nielsen; Charles M Perou; Vincent L Cryns
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma.

Authors:  Hong Lok Lung; Cathy Carfield Lo; Carmen Chak Lui Wong; Arthur Kwok Leung Cheung; Ka Fu Cheong; Nathalie Wong; Fung Mei Kwong; King Chi Chan; Evan Wai Lok Law; Sai Wah Tsao; Daniel Chua; Jonathan Shuntong Sham; Yue Cheng; Eric J Stanbridge; Gavin P Robertson; Maria Li Lung
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

3.  Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey.

Authors:  An-Gao Xu; Zhi-Jin Yu; Bo Jiang; Xin-Ying Wang; Xu-Hui Zhong; Ji-Hong Liu; Qiu-Yun Lou; Ai-Hua Gan
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

4.  ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.

Authors:  Pei-Yin Ho; Shih-Chieh Chueh; Shyh-Horng Chiou; Shuo-Meng Wang; Wei-Chou Lin; I-Liang Lee; Hsin-Yi Yang; Hsiang-Chi Peng; Ming-Kuen Lai
Journal:  Urol Oncol       Date:  2012-03-13       Impact factor: 3.498

5.  Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.

Authors:  Qi Tang; Yue-Fang Liu; Xiao-Jing Zhu; Yu-Hua Li; Jin Zhu; Jian-Ping Zhang; Zhen-Qing Feng; Xiao-Hong Guan
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

6.  Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts.

Authors:  Rooban B Nahomi; Benlian Wang; Cibin T Raghavan; Oliver Voss; Andrea I Doseff; Puttur Santhoshkumar; Ram H Nagaraj
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

7.  Pseudophosphorylated αB-crystallin is a nuclear chaperone imported into the nucleus with help of the SMN complex.

Authors:  John den Engelsman; Chantal van de Schootbrugge; Jeongsik Yong; Ger J M Pruijn; Wilbert C Boelens
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

8.  MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Authors:  Dengbo Ji; Zhiguo Chen; Ming Li; Tiancheng Zhan; Yunfeng Yao; Zhiqian Zhang; Jianzhong Xi; Li Yan; Jin Gu
Journal:  Mol Cancer       Date:  2014-04-23       Impact factor: 27.401

9.  SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.

Authors:  Ida V Lundberg; Anna Löfgren Burström; Sofia Edin; Vincy Eklöf; Åke Öberg; Roger Stenling; Richard Palmqvist; Maria L Wikberg
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer.

Authors:  Cheng Chen; Lingyan Wang; Qi Liao; Yi Huang; Huadan Ye; Fei Chen; Leiting Xu; Meng Ye; Shiwei Duan
Journal:  Diagn Pathol       Date:  2013-12-10       Impact factor: 2.644

View more
  17 in total

Review 1.  Therapeutic potential of α-crystallin.

Authors:  Ram H Nagaraj; Rooban B Nahomi; Niklaus H Mueller; Cibin T Raghavan; David A Ammar; J Mark Petrash
Journal:  Biochim Biophys Acta       Date:  2015-04-01

2.  A monoclonal antibody targeted to the functional peptide of αB-crystallin inhibits the chaperone and anti-apoptotic activities.

Authors:  Rooban B Nahomi; Sandip K Nandi; Ram H Nagaraj
Journal:  J Immunol Methods       Date:  2019-02-06       Impact factor: 2.303

Review 3.  αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target.

Authors:  Dmitry Malin; Vladimir Petrovic; Elena Strekalova; Bhawna Sharma; Vincent L Cryns
Journal:  Pharmacol Ther       Date:  2016-01-25       Impact factor: 12.310

4.  EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner.

Authors:  Azadeh Arabzadeh; Kevin McGregor; Valérie Breton; Lauren Van Der Kraak; Uri David Akavia; Celia M T Greenwood; Nicole Beauchemin
Journal:  Oncotarget       Date:  2017-11-01

5.  Differential phosphorylation-based regulation of αB-crystallin chaperone activity for multipass transmembrane proteins.

Authors:  Michela Ciano; Simona Allocca; Maria Camilla Ciardulli; Lucrezia Della Volpe; Stefano Bonatti; Massimo D'Agostino
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

6.  Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers.

Authors:  Miriam Buttacavoli; Nadia Ninfa Albanese; Elena Roz; Ida Pucci-Minafra; Salvatore Feo; Patrizia Cancemi
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

7.  Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.

Authors:  Lorea Valcarcel-Jimenez; Alice Macchia; Natalia Martín-Martín; Ana Rosa Cortazar; Ariane Schaub-Clerigué; Mikel Pujana-Vaquerizo; Sonia Fernández-Ruiz; Isabel Lacasa-Viscasillas; Aida Santos-Martin; Ana Loizaga-Iriarte; Miguel Unda-Urzaiz; Ivana Hermanova; Ianire Astobiza; Mariona Graupera; Julia Starkova; James Sutherland; Rosa Barrio; Ana M Aransay; Arkaitz Carracedo; Verónica Torrano
Journal:  Cell Death Dis       Date:  2018-10-11       Impact factor: 8.469

8.  High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.

Authors:  Lin Tan; Ling Sha; Ning Hou; Mei Zhang; Qian Ma; Chuanbing Shi
Journal:  Biosci Rep       Date:  2019-06-18       Impact factor: 3.840

9.  Alpha B-crystallin C-802G polymorphism and colorectal cancer susceptibility and clinical outcome in Chinese population.

Authors:  Xiao Wu; Yuan-Zheng Zheng; Bin Han; Ke Wang
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

Review 10.  Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities.

Authors:  Abdullah Hoter; Hassan Y Naim
Journal:  Cancers (Basel)       Date:  2019-09-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.